Evidence used
- No CISA KEV confirmation is currently recorded.
- EPSS is 0.98% for the current model date.
BlackTreeCVE IntelligenceUnknown · Cisco IOS XE
Official source article: Cisco CISCO-SA-20180328-WFW ↗. Check the applicable product and release in the original source.
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Fix not verifiedA vulnerability in the web-based user interface (web UI) of Cisco IOS XE Software could allow an authenticated, remote attacker to write arbitrary files to the operating system of an affected device. The vulnerability is due to insufficient input validation of HTTP requests that are sent to the web UI of the affected software. An attacker could exploit this vulnerability by sending a malicious HTTP request to the web UI of the affected software. A successful exploit could allow the attacker to write arbitrary files to the operating system of an affected device. Cisco Bug IDs: CSCvb22645.
A vulnerability in the web-based user interface (web UI) of Cisco IOS XE Software could allow an authenticated, remote attacker to write arbitrary files to the operating system of an affected device. The vulnerability is due to insufficient input validation of HTTP requests that are sent to the web UI of the affected software. An attacker could exploit this vulnerability by sending a malicious HTTP request to the web UI of the affected software. A successful exploit could allow the attacker to write arbitrary files to the operating system of an affected device. Cisco Bug IDs: CSCvb22645.
The product receives input or data, but it does not validate or incorrectly validates that the input has the properties that are required to process the data safely and correctly.
An attacker operating through a network path may attempt exploitation with elevated privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
A vulnerability in the web-based user interface (web UI) of Cisco IOS XE Software could allow an authenticated, remote attacker to write arbitrary files to the operating system of an affected device. The vulnerability is due to insufficient input validation of HTTP requests that are sent to the web UI of the affected software. An attacker could exploit this vulnerability by sending a malicious HTTP request to the web UI of the affected software. A successful exploit could allow the attacker to write arbitrary files to the operating system of an affected device. Cisco Bug IDs: CSCvb22645.
The product receives input or data, but it does not validate or incorrectly validates that the input has the properties that are required to process the data safely and correctly.
An attacker operating through a network path may attempt exploitation with elevated privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.
CWE-20: Improper Input Validation. The product receives input or data, but it does not validate or incorrectly validates that the input has the properties that are required to process the data safely and correctly.
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:H/A:NCommon Vulnerability Scoring System 3.1: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 28 Mar 2018 · Last source change 2 Dec 2024, 20:51 UTC · CWE-20 · Improper Input Validation
Missing structured fields: affected product. Missing data is not evidence of low risk; review the primary advisory.